Glonghui March 26 | Component stock Summit Therapeutics Plc., led by 9.91%, Voyager Therapeutics up 9.34%, Anavex Life Sciences up 8.02%, and Day One Biopharmaceuticals up 5.13%; OmniaB is currently down 2.07%, Replimune down 2.24%, Arcturus Therapeutics Holdings Inc. fell 3.75%, while bluebird bio fell 18.39% and is currently the worst performer.
纳斯达克生物科技指数涨超0.4%
The Nasdaq biotech index rose more than 0.4%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.